The clinical efficacy of short-term steroid treatment in multilevel anterior cervical arthrodesis.

BACKGROUND CONTEXT

Dysphagia is the most common complication of anterior cervical discectomy and fusion (ACDF), and it is closely related to prevertebral soft-tissue swelling (PSTS). A few studies have found that local or systemic methylprednisolone is effective against laryngopharyngeal edema and airway obstruction.

PURPOSE

To assess the effectiveness of short-term use of systemic methylprednisolone in relieving dysphagia and decreasing PSTS during the hospitalization period.

STUDY DESIGN

A prospective study.

PATIENT SAMPLE

Forty patients who underwent multilevel (more than three levels) ACDF with same plate fixation.

OUTCOME MEASURE

Radiologic and clinical measures.

METHODS

Twenty of these patients were given 250 mg of methylprednisolone intravenously (IV) four times a day only for 24 hours after the operation (at 6-hour intervals), whereas the remaining 20 did not receive methylprednisolone and served as controls. We used the Bazaz scale to compare the degree of dysphagia between groups during the hospitalization period. We used the C-spine lateral view to assess the degree of pre- and postoperative PSTS from C2 to C7. At the final follow-up, we assessed the relationship between the occurrence of complications and steroid use.

RESULTS

The degree of dysphagia according to the Bazaz scale was less severe in the group that received methylprednisolone (p values; postoperative Day [POD] 2∼5<.05, POD 6=.014, POD 7=.019). Prevertebral soft-tissue swelling was also significantly lower in the group that received methylprednisolone (p values; POD 2∼POD 5 <.005, POD 1=.061, POD 6=.007, POD 7=.091). The amount of PSTS and dysphagia did not differ according to sex, age, smoking history, or length of surgery. The period of hospitalization in the experimental group was shorter than in the control group. No complications related to steroid use were found at the final follow-up.

CONCLUSIONS

The short-term use of systemic methylprednisolone after ACDF appears to be effective in relieving dysphagia and decreasing the PSTS. Furthermore, the short-term use of methylprednisolone was not associated with any adverse effects of short-term IV steroid usage, such as peptic ulcer disease or postoperative infection. The clinical use of methylprednisolone in relieving dysphagia and decreasing PSTS deserves consideration during the early postoperative period.